Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Intraductal, Noninfiltrating × palbociclib × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 12 Ovarian Neoplasms 4 Neoplasms 3 Neoplasm Metastasis 3 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Endometrial Neoplasms 2 Uterine Cervical Neoplasms 1 Unilateral Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms by Site 1 Malignant Female Reproductive System Neoplasm 1 Lymphoma, Mantle-Cell 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Leukemia, Myeloid, Acute 1 Kidney Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1 ER+ HER2- Advanced Breast Cancer 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Breast Diseases 1

Interventions

Tamoxifen 6 Specimen Handling 4 exemestane 3 Letrozole 3 Anastrozole 3 Biopsy 2 poly ICLC 1 fezolinetant 1 elacestrant 1 Testosterone 1 Surveys and Questionnaires 1 Selective Estrogen Receptor Modulators 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiation Dose Hypofractionation 1 Radiation 1 Neoadjuvant Therapy 1 Multicenter Studies as Topic 1 Medicare 1 Mastectomy, Segmental 1 Mastectomy 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Diet Records 1 Colony-Stimulating Factors 1 CD2-associated protein 1 Blood Specimen Collection 1 Aromatase Inhibitors 1 4-hydroxy-N-desmethyltamoxifen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡